Month: September 2025

Shoucheng Moves Upstream: Materials Cement Robotics Ecosystem

acn

HONG KONG, Sep 2, 2025 – (ACN Newswire via SeaPRwire.com) – In the first half of 2025, Shoucheng Holdings reported revenue of HK$731 million, up 36% year-on-year, and attributable net profit of HK$339 million, up 30% year-on-year. Revenue from its capital recycling segment surged 69% year-on-year, highlighting the effectiveness of its “Asset Operation + Capital Recycling” […]

Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT

jcn

Massachusetts, USA, September 2, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Corporation (“MC”) is pleased to announce its participation in a third-party allotment of shares by Commonwealth Fusion Systems LLC (Headquarter: Massachusetts, USA, Representative: Bob Mumgaard, “CFS”), a fusion energy start-up originating from MIT *1. This investment was made in collaboration with a consortium of […]

Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework “SAFe(R)”

jcn

TOKYO, September 2, 2025 – (JCN Newswire via SeaPRwire.com) – Hitachi, Ltd. (TSE:6501, “Hitachi”) has been certified as a Gold Partner*1 of Scaled Agile, Inc. (“SAI”), the provider of SAFe®, the world’s most trusted system for business agility. SAFe is a management framework that supports organizational transformation and business agility, helping to enhance competitiveness and […]

Top Global Music Industry Leaders Convene at 2025 TME Chinese Music Impact Summit

admin

On August 23, Tencent Music Entertainment Group (TME) successfully hosted the “2025 TME Chinese Music Impact Summit” in Macau. As the first annual international summit in China dedicated to providing exchange and collaboration opportunities for Chinese music’s global expansion, the event was held under the theme “China to the World: The Sounds of Tomorrow.” Through four […]

FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

jcn

TOKYO and CAMBRIDGE, MA, August 30, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for once weekly […]

TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) – Applications for Research Projects Open on September 1

jcn

TOKYO, Sept 1, 2025 – (JCN Newswire via SeaPRwire.com) – TANAKA Memorial Foundation (Representative Director: Hideya Okamoto) has announced that it will be accept applications for research themes for FY2025 Precious Metals Research Grants from September 1 to November 28, 2025. This grant program aims to contribute to the development of science and industry by promoting […]

Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building

jcn

TOKYO, Japan, August 29, 2025 – (JCN Newswire via SeaPRwire.com) – Honda Motor Co., Ltd. (Honda) today announced new plans regarding the relocation of its global head office function: 1) Honda will relocate its global head office function, before the end of 2029*, to the high-rise office floors of a new mixed-use building currently under construction […]

Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma

jcn

TOKYO, August 29, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has received orphan drug designation for anticancer agent the EZH2*1 inhibitor tazemetostat hydrobromide (generic name, product name “Tazverik® Tablets 200 mg”, “tazemetostat”) for unresectable INI1*2-negative epithelioid sarcoma that has progressed after chemotherapy, […]

Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage

jcn

Completion of strategic acquisition affirms Hitachi Energy’s position as a market and technology leader in advancing energy storage innovation – a cornerstone of secure energy transitions Power electronics with advanced digital capabilities are critical to ensure reliability and stability of the electric grid Zurich, Switzerland, August 28, 2025 – (JCN Newswire via SeaPRwire.com) – Hitachi […]